𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors

✍ Scribed by N. Soufir; S. Queille; M. Liboutet; O. Thibaudeau; F. Bachelier; G. Delestaing; B.C. Balloy; J. Breuer; A. Janin; L. Dubertret; C. Vilmer; N. Basset-Seguin

Book ID
108669153
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
140 KB
Volume
156
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Overexpression of MDM-2 mRNA and mutatio
Overexpression of MDM-2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines
✍ Ya-Tse Cheng; Yu-Ling Li; Jeng Dau Wu; Shih-Bin Long; Tzong-Shin Tzai; Ching-Che πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 840 KB

## Abstract To investigate the importance of oncogenes and tumor suppressor genes in bladder carcinogenesis, we determined the status of the expression of the __MDM‐2__ and __p53__ genes and genetic alterations in the __p53__ gene in five bladder carcinoma cell lines and one kidney urothelial carci

Frequency of mutation and deletion of th
Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population
✍ K Biden; J Young; R Buttenshaw; J Searle; G Cooksley; D B Xu; B Leggett πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 476 KB

The tumor suppressor gene CDKN2A (MTS1/p16), located on chromosome 9p21, is inactivated in a variety of tumors including melanomas and tumors of the biliary tract, pancreas, and stomach. The aim of the present study was to determine whether this gene is inactivated in hepatocellular carcinoma (HCC).